90
Participants
Start Date
May 6, 2013
Primary Completion Date
June 11, 2015
Study Completion Date
June 11, 2015
Etanercept
Administered by subcutaneous injection
Methotrexate
Background methotrexate at least 15 mg weekly
Research Site, Smithtown
Research Site, Duncansville
Research Site, Chesapeake
Research Site, Roanoke
Research Site, Clarksburg
Research Site, Charlotte
Research Site, Lawrenceville
Research Site, Brandon
Research Site, Tampa
Research Site, Largo
Research Site, Palm Harbor
Research Site, Dunedin
Research Site, Tuscaloosa
Research Site, Hixson
Research Site, Paducah
Research Site, Bowling Green
Research Site, Middleburg Heights
Research Site, Battle Creek
Research Site, Lincoln
Research Site, Houston
Research Site, Victoria
Research Site, Corpus Christi
Research Site, Austin
Research Site, Denver
Research Site, Scottsdale
Research Site, Covina
Research Site, San Diego
Research Site, Victorville
Research Site, Hemet
Research Site, Murrieta
Research Site, Seattle
Research Site, Fall River
Research Site, Victoria
Research Site, Quispamsis
Research Site, St. John's
Research Site, St. John's
Research Site, Burlington
Research Site, Hamilton
Research Site, Mississauga
Research Site, Toronto
Research Site, Montreal
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Caguas
Lead Sponsor
Amgen
INDUSTRY